Medical Economics April 2, 2025
Omid Veiseh, PhD, Chris Mazzolini

Omid Veiseh, PhD, faculty director of the Rice Biotech Launchpad, discusses his organization’s mission to create innovative biotechnology based on patient need.

The Rice Biotech Launch Pad has set an ambitious course to transform lab discoveries into real-world solutions for patients, and at the center of this effort is Omid Veiseh, PhD, its faculty director and a professor of bioengineering at Rice University.

Veiseh sat down with Medical Device & Technology, a brand of Medical Economics, too ffer his insights into how Rice University’s incubator fast-tracks promising biotech ventures — from cutting-edge immunotherapies to advanced diagnostic platforms — by pairing clinicians and researchers with entrepreneurs, investors and industry partners.

“Our projects all start with a clinician founder,” Veiseh said. “It’s...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Conferences / Podcast, Pharma / Biotech, Provider, Trends
Pharma Dodges The Tariff Bullet — But For How Long?
Noom, LillyDirect pharmacy provider partner to increase access to Zepbound
PBM Private Labeling Boosts Biosimilars, Raises Concerns
Q&A: How can drug repurposing lower drug costs and improve care?
BC researchers receive $49M for genomics projects

Share This Article